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For personal usSummary Background/Objective: Currently, due to lack of optimal donors, more marginal
organs are transplanted. Therefore, there is a high interest to ameliorate preischemic organ
preservation, especially for critical donor organs. In this regard, a new histidine-
tryptophane ketoglutarate (HTK-N) solution has been designed and its protective efficacy
was compared with the standard preservation solutionsdUniversity of Wisconsin solution
and standard HTK or Custodiol (Bretschneider’s solution).
Methods: Seventy-two landrace pigs were included into the study, as donors and recipients.
The donor kidneys were perfused during explantation with cold University of Wisconsin solu-
tion (nZ 12), standard HTK (nZ 12), or HTK-N solutions (nZ 12), kept in the respective pres-
ervation solution at 4C for 30 hours, implanted in the recipient pigs, and reperfused. The pigs
survived in daily control for 7 days. The serum creatinine and blood urea nitrogen were as-
sessed in pre- and postreperfusion phase on the 3rd day and 7th day posttransplantation. Addi-
tionally, tissue samples were taken to analyze the histopathological degree of tubular injury
and regeneration before and after reperfusion.declare that they have no competing interests.
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For personalResults: The three preservation groups were comparable in age, body weight, and hemody-
namic parameters. According to statistical proof, they differed in none of the control param-
eters.
Conclusion: Although the new preservation HTK solution is in several points a well-thought-out
modification of the standard HTK solution, its preservation efficacy, at least for kidney preser-
vation in a pig model for 30 hours, seems to be comparable to the current used solutions. A real
advantage, however, could be confirmed in clinical settings, where marginal organs may influ-
ence the clinical outcome.
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creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Organ preservation plays an important role in solid organ
transplantation. It has a great influence on ischemia
reperfusion injury and early graft function as well as long-
term graft survival.1e3 University of Wisconsin (UW) and
histidine-tryptophan ketoglutarate (HTK) solutions are
currently used as the routine preservation solutions in many
transplant centers world-wide. They have shown about the
same efficacy in a remarkable number of studies during the
past years.4e7 They have, however, functional limitations in
protective efficacy against ischemia reperfusion injury,
especially in a warm or even cold ischemic period or in
organs with extended donor criteriadthe so called mar-
ginal organs.8e12
In order to reduce these limitations, a new version of
the standard HTK solution, HTK-new solution (HTK-N) has
been introduced. This solution differs from the routine
HTK with increased antioxidative capacity and cold
tolerance by the addition of deferoxamine and LK614.
Deferoxamine works intracellularly as an iron chelator,
and LK614 is a catalase-mimic and catalyzes the reduction
of H2O2 to H2O in cells. In rat heart and liver models the
superiority of this new preservation solution could be
shown in the preservation of coronary vessel structure,
endothelial function, improvement of myocardial
contractility and relaxation after heart transplantation,
and promising therapeutic strategies for attenuation of
cold storage injury.13e15 The underlying hypothesis claims
that very small intracellular pools of iron together with
H2O2 may play a critical role in the formation of the haz-
ardous free radicals.15e20
Furthermore, there is a certain reduction of histidine
buffer in favor of N-acetyl-histidine in HTK-N, assuming
that histidine could be degraded to toxic products by
reactive oxygen or nitrogen species. Besides, the solution
contains very high magnesium and higher calcium con-
centrations for antagonizing the destabilizing effects of
high magnesium in cell membranes by calcium antago-
nism.21,22 Because mannitol in hepatocytes is not
completely impermeable, the osmolyte mannitol is
replaced by saccharose.23
In this study, our aim is to evaluate the HTK-N solution in
a porcine kidney transplantation (KTx) model with a 30-
hour cold ischemia time and to compare it with the stan-
dard HTK solution and UW solution.nonymous User (n/a) at Nazarbayev Unive
 use only. No other uses without permission2. Methods
2.1. Animal rights
The Governmental Committee on Animal Care approved the
experiments and animals were given humane care in
compliance with institutional guidelines. Following
completion of the experimental protocol, the animals were
sacrificed with an intravenous injection of kalium chloride
(2 mmol/kg) in deep anaesthesia.
2.2. Quality of assurance statement
The study was performed in accordance with the Principles
of Good Laboratory Practice, annex of paragraph 19a,
section 1 of the German chemical law of July 25, 1994.
2.3. Study design
Seventy two Landrace pigs (30e40 kg) were divided into
three groups: Group 1 (GI): UW (12 donors and 12 re-
cipients); Group 2 (GII): standard HTK (12 donors and 12
recipients); and Group 3 (GIII): HTK-N (12 donors and 12
recipients). Table 1 summarizes the similarities and dif-
ferences between these solutions. In each group, the or-
gans were perfused with the respective solution and were
implanted after 30 hours of ischemia at 4C using the
standard technique in nephrectomized recipients. The
kidney recipients were followed-up for 7 days post-
operatively, until final evaluation of blood and tissue pa-
rameters (Figure 1 and Table 2).
2.4. Preoperative preparation, anesthesia, and
cardiovascular monitoring
Preoperative preparation for all animals included fasting
for 12 hours, allowing free access to water only, and
application of a standardized narcotic protocol with pre-
medication: azaperon 8 mg/kg intramuscular, midazolam
0.5e0.7 mg/kg intramuscular, ketamine 5 mg/kg intrave-
nously (i.v.), and atropine sulfate 1 mg i.v., followed by
endotracheal intubation. Pressure controlled ventilation
was done in a half-closed system. The ventilation parame-
ters were adjusted to the frequency of 11 minutes, tidal
volume of 300 mL, air 1.5e2.0 L/min, O2 0.5e1.0 L/min,rsity from ClinicalKey.com by Elsevier on June 05, 2018.
. Copyright ©2018. Elsevier Inc. All rights reserved.
Table 1 The similarities and differences between Uni-
versity of Wisconsin solution, standard histidine-tryptophan
ketoglutarate solution, and new histidine-tryptophan
ketoglutarate solution.
Constituents (mmol/L) UW Standard HTK HTK-N
Naþ 30 15 16
Kþ 115 10 10
Mgþþ 5 4 8
Caþþ 0 0.01 0.02
Cl d 50 30
SO4
2 5 d d
Lactobionate 100 d d
HPO4 20 d d
H2PO4 5 d d
Histidine d 180 124
Histidine$HCl d 18 d
N-acetylhistidine d d 57
Aspartate d d 5
Tryptophan d 2 2
Oxoglutarate 1 1 2
L-arginine d d 3
Glycine d d 10
L-alanine d d 5
Saccharose d d 33
Raffinose 30 d d
Manitol d 30 d
Glutatione 3 d d
Adenosine 5 d d
HAES 50 [g/L] d d
Deferoxamine d d 0.025
LK614 d d 0.0075
Calculated osmolarity
(mosm/L)
369 311 302
Buffer capacity in the pH range 7.0/6.0 (mmol Hþ/L):
At 25C 85 57
At 5C 97 74
HAES Z Hydroxyethyl starch; HTK-N Z new histidine-
tryptophan ketoglutarate solution; standard HTK Z standard
histidine-tryptophan ketoglutarate solution; UWZ University of
Wisconsin solution.
108 M. Golriz et al.N2O 1.5e2.0 L/min, and isoflurane 0.75e1.5%. The arterial
blood gases were kept between 75e100 mmHg pO2 and
35e42 mmHg pCO2. Cardiocirculatory invasive measure-
ments included central venous pressure (CVP) and mean
arterial pressure (MAP), using an inserted catheter via the
internal jugular vein and common carotid artery,
respectively.
2.5. Surgical procedures
2.5.1. Explantation and preservation
Through a full-length midline laparotomy, kidneys were
mobilized and dissected from their perirenal tissue. The
vessels were dissected gently. Mobilization of the adrenal
gland and division of its vein from the renal vein were fol-
lowed by ligation and division of the lateral lumbar ar-
teries. After heparinization (25,000 IU) and insertion of the
catheter in the aorta abdominalis near the branches ofDownloaded for Anonymous User (n/a) at Nazarbayev Universi
For personal use only. No other uses without permission. Crenal arteries, the respective preservation solution was
infused with a controlled constant pressure of 120 mmHg
and the renal veins were cut to allow emitting the perfusion
solution. According to the different application standards,
the perfusion volume in the UW group was 500 mL, and
perfusion time was 5 minutes. In the standard HTK and HTK-
N groups, the perfusion volume was 2 L, and the perfusion
took 10 minutes. Kidney explantation was performed with
protection of the periureteral fat tissue to preserve blood-
vessels of the ureter. Along with the kidney and its
respective vessels, the ureter was cut long enough for later
ureterocystostomy (Figure 2). After procurement, the or-
gans were kept in the respective 4C preservation solution
for 30 hours of cold ischemia.
2.5.2. Implantation
After the 30-hour cold ischemia time and biopsy, the kid-
neys were transplanted orthotopically in the kidney lodge
after both-side nephrectomy of the recipients. The venous
anastomosis was constructed end to side with continuous
single layer 5/0 prolene-sutures between the renal vein and
vena cava inferior. A similar arterial end-to-side running
suture anastomosis with 5/0 prolene was performed after-
wards between the renal artery and aorta (Figure 3A). After
heparinization with 250 IU/kg i.v., the reperfusion started
by declamping the renal veins and arteries. Thereafter, the
ureter anastomosis was performed using the ureter-
oneocystostomy technique by Lich-Gregoir with a 4/0 PDS
sutures (Figure 3B). During the operation, the recipient
received 1e2.5 g metamizole i.v, 100 mL/kg isotonic solu-
tion infusion (NaCl 0.9% or Ringer), 2.5 mg/kg i.v enro-
floxacin, and 40 mg i.v. pantozol.
2.5.3. Peri- and postoperative monitoring
After the operation the permanent central venous catheter
was fixed to the subcutaneous tissue of the neck of pigs and
the animals were transferred to the university’s animal
enclosure and were followed-up under controlled condition
for 7 days. They received 250 mg i.v./d methylprednisolone
and 0.05 mg/kg i.v./d tacrolimus as imunosupressants, and
0.02 mg/kg i.v./daily buprenorphine and 500 mg/d meta-
mizole as analgesics. To prevent stress ulcers, vascular
thrombosis, and infection, pantozol 40 mg i.v./d, enox-
aparin 40 mg subcutaneous/d, and enrofloxacin 2.5 mg/kg
i.v./d were given, respectively. Mannitol, glucose, and
isotonic solution (NaCl) were infused regarding urine output
and circulatory stability of the animals (Table 3). Blood
samples were taken before and after reperfusion, as well as
on Day 3 and Day 7 postoperatively to control serum
creatinine, blood urea nitrogen (BUN), hemoglobin (Hb),
and hematocrit (Hct; Table 2).
2.5.4. Histopathological assessment
In order to evaluate the histological changes of the trans-
planted organs, biopsies were taken three times: after cold
ischemia time, 30 minutes after reperfusion, and on the 7th
posttransplant day (Figure 1). The biopsies were fixed in 5%
formaldehyde. The tubular injury was classified in a semi-
quantitative scoring system for ranking the progress of
possible tissue damages (Table 4). According to this scoring
system the histological outcome of all three groups at each
sampling time was ranked.ty from ClinicalKey.com by Elsevier on June 05, 2018.
opyright ©2018. Elsevier Inc. All rights reserved.
a. 
HTK-N = new histidine-tryptophan ketoglutarate solution; KTx = porcine kidney transplantation model; standard HTK = standard histidine-
tryptophan ketoglutarate solution; UW = University of Wisconsin solution.
Group 1: 
Preservation 
with UW (n
= 12)
Group 2: 
Preservation 
with HTK
(n = 12)
Group 3:
Preservation 
with new 
HTK (n =
12)
Cold ischemia time 
30 h 4°C
Group 1: 
KTx in the 
right groin 
(n = 12)
Group 2: 
KTx in the 
right groin 
(n = 12) 
Group 3:
KTx in the 
right groin 
(n = 12)
Post-operation follow-
up 7 d
72 
pigs
Laparotomy
Tx-nephrectomy
biopsy
Explantation Implantation Follow-up Evaluation
Figure 1 Study design from beginning to final evaluation of the transplanted kidneys. HTK-N Z new histidine-tryptophan
ketoglutarate solution; KTx Z porcine kidney transplantation model; standard HTK Z standard histidine-tryptophan ketogluta-
rate solution; UWZ University of Wisconsin solution.
Preservation solution in kidney transplantation 1092.6. Statistical analysis
All results are quoted as mean  standard error of the
mean. Statistical analysis was performed using IBM SPSS
Statistics, version 22 (Licensed Materials e Property of IBM.
ª Copyright IBM Corp. 1983, 2013.), using KruskaleWallis
and analysis of variance tests where appropriate. The null
hypothesis was rejected when p < 0.05.
3. Results
3.1. Cardiovascular results
The average weights of the experimental animals between
the three recipient groups were not significantly different
(30.2  2.7 kg in GI, 30.3  2.8 kg in GII, and 30.2  2.7 kg
in GIII). The average operating duration was 215  8 mi-
nutes in GI, 210  9 minutes in GII, and 211  8 minutes in
GIII. Warm ischemia time in all groups was invariably < 45
minutes. Anastomosing time took w35 minutes in each
group. Before transplantation, MAP and CVP in GI were
66  2.5 mmHg and 9.6  0.3 cmH2O, 69  2.1 mmHg and
9.3  0.2 cmH2O in GII, and 64  1.9 mmHg and 9.4  0.3
cmH2O in GIII, respectively. After transplantation MAP andTable 2 Timetable of the laboratory and histhopatho-
logical evaluations during the study.
Sample Prereperfusion Postreperfusion Postoperative
day
1 2 3 4 5 6 7
Blood X X X X
Biopsy X X X
Downloaded for Anonymous User (n/a) at Nazarbayev Unive
For personal use only. No other uses without permissionCVP were 73  3.1 mmHg and 11.2  1 cmH2O in GI,
77  2.5 mmHg and 12.1  0.8 cmH2O in GII, and
74  2.0 mmHg and 10.9  0.8 cmH2O in GIII, respectively.
Neither the differences between the groups nor the dif-
ferences between pre- and posttransplantation were sta-
tistically significant. After transplantation all recipientsFigure 2 Explanted kidney after a 30-hour cold ischemia
time [(A) renal vein; (B) renal artery with the carrel patch; and
(C) urethra with periurethral tissue].26
rsity from ClinicalKey.com by Elsevier on June 05, 2018.
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Figure 3 Implanted kidney after reperfusion. (A) The arte-
rial and venous anastomosis are completed; (B) transplanted
kidney after reperfusion and completed ureterocystostomy.26
Table 3 Our standard protocol for peri- and postoperative
management.
Analgesia Metamizol
(Novalgin)
50 mg/kg/d i.v.
Pritramid (Dipidolor) 0.5 mg/kg/d i.v.
Immunosupression Tacrolimus (Prograf) 2 g/d i.v.
Methylprednisolone
(Urbason)
250 mg/d i.v.
Antibiosis Meziocilline
(Baypen)
2 g/d i.v.
Thrombosis
prophylaxis
Enoxaparine
(Clexane)
40 mg/d s.c.
Stress ulcer
prophylaxis
Pantoprazole
(Pantozol)
40 mg/d i.v.
Isotonic fluid NaCl 0.9% 1st postoperative
d:2 L i.v.
2nd postoperative
d: 2 L i.v.
i.v. Z intravenous; s.c. Z subcutaneous.
Table 4 Semiquantitative scoring system.
Semiquantitative scoring
Intact tubuli with epithelial brush borders 0
Focal acute tubular necrosis 1
Acute tubular necrosis 2
Focal loss of ciliated borders in epithelial cells 3
Loss of ciliated borders in epithelial cells 4
Focal flattening & vacuolization of the epithelial cells 5
Flattening & vacuolization of the epithelial cells 6
Focal denudation of basement membrane 7
Denudation of basement membranes 8
110 M. Golriz et al.showed a mild decrease of Hct and Hb. Hct and Hb in GI
from 33  3% and 11.35  1.29 g/dL dropped to 31  3% and
11.19  1.63 g/dL, in GII from 31  2% and 10.66  1.11 g/
dL to 27  6% and 10.09  1.85 g/dL, and in GIII from
33  2% and 11.86  1.30 g/dL to 31  6% and
11.49  2.78 g/dL. The differences between pre- and
posttransplantation, as well as between the three groups
were not statistically significant.
3.2. Metabolic studies
3.2.1. General criteria
All implanted kidneys showed a homogenous red color
macroscopically within 5 minutes after reperfusion
(Figure 3B). The majority of grafts started to excrete urine
within the first 24 hours of reperfusion. It happened in 11 of
12 cases in GI, 12 of 12 cases in GII, and 10 of 12 cases in
GIII.
3.2.2. Parameters of graft function
Comparing pre- and postischemic serum potassium con-
centration showed a postischemic increase in all graft re-
cipients up to pathological values. This increase was minor
in the groups UW and standard HTK, but obvious in the HTK-
N group. The values, however, were highly variable and
consequently not significantly different. Serum creatinine
in donors were 1.7  0.3 mg/dL in GI, 1.45  0.3 mg/dL in
GII, and 1.54  0.3 mg/dL in GIII. The differences between
these values were not statistically significant. During the
first 3 days after transplantation in all three groups,Downloaded for Anonymous User (n/a) at Nazarbayev Universi
For personal use only. No other uses without permission. Ccreatinine increased to pathological values. This increase
was minor in the HTK-N group as compared with the other
groups, but reached no statistical significance. In Group I, it
reached 9.6  2.3 mg/dL, in Group II 10.5  4.25 mg/dL,
and in Group III 8.5  4.8 mg/dL (Figure 4).
BUN also increased during the first 3 days postoperation
to the pathological values in all three groups. BUN during
this interval rose from 23  6 mg/dL to 240  125 mg/dL in
Group I, and from 22  9 mg/dL to 251  104 mg/dL in
Group II. Neither before implantation nor on Day 3 post-
operation, the values differed significantly. The data are
summarized in Figure 5. In urine, creatinine concentration
in the three experimental groups was higher preischemi-
cally than postischemically. During reperfusion, it
increased to around 50 mg/100 mL in all three groups. This
increase was independent of the preservation used and
statistically not different (Figure 6). The levels of urine
osmolarity in different time points were comparable in all
groups (Figure 7).3.3. Histopathological results
The biopsies were evaluated for tubular injury and nek-
rosis. The tubular injury was classified based on the semity from ClinicalKey.com by Elsevier on June 05, 2018.
opyright ©2018. Elsevier Inc. All rights reserved.
Figure 4 Mean values and standard deviations of serum
creatinin in three groups of UW, standard HTK, and HTK-N
during the experimental study (pre-, postreperfusion, 3rd day
and 7th day after transplantation). HTK-N Z new histidine-
tryptophan ketoglutarate solution; standard HTK Z standard
histidine-tryptophan ketoglutarate solution; UWZ University
of Wisconsin solution.
Figure 6 Mean values and standard error of mean of urine
creatinine (mg/100 mL) in three groups of UW, standard HTK,
and HTK-N, during the experimental study (pre-, post-
reperfusion, 3rd day and 7th day after transplantation). HTK-
NZ new histidine-tryptophan ketoglutarate solution; standard
HTK Z standard histidine-tryptophan ketoglutarate solution;
UWZ University of Wisconsin solution.
Preservation solution in kidney transplantation 111quantitative scoring system shown in Table 4. One hour
after reperfusion, histopathological deterioration could be
seen in 13% of kidneys preserved by UW and standard HTK,
and in 15% preserved by HTK-N. On posttransplant Day 7,
we could see the sign of regeneration in all kidneys. When
classifying the extent of this regeneration into A 75%, B
25e75%, C< 25%, UW kidneys showed 70%, HTK 80%, and
HTK-N 70% of Level A regeneration. Level B was seen in
about 30% of UW Kidneys, in 10% of standard HTK kidneys,
and in 20% of HTK-N kidneys. Level C could be seen in none
of the UW kidneys, 10% of standard HTK, and 20% of HTK-N
kidneys. Considering the extent of the regeneration on Day
7 posttransplant, UW, standard HTK, and HTK-N reached
16%, 12%, and 10% histopathological improvement,
respectively (Figure 8). Neither deterioration nor
improvement of the histopathological structure showed
significant difference between the solutions in each biopsyFigure 5 Mean values and standard deviations of serum urea
in three groups of UW, standard HTK, and HTK-N during the
experimental study (pre-, postreperfusion, 3rd day and 7th day
after transplantation). HTK-N Z new histidine-tryptophan
ketoglutarate solution; standard HTK Z standard histidine-
tryptophan ketoglutarate solution; UWZ University of Wis-
consin solution.
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reperfusion: p Z 0.8; 7th day: p Z 0.5; Figure 9).4. Discussion
The aim of optimizing graft quality has resulted in intensive
experimental and clinical efforts to improve the ischemic
tolerance of the organs. One of the most important goals is
to improve the preserving quality of the current preserva-
tion solutions or to invent new ones. In our study, we have
compared HTK-N with the two clinically established pres-
ervation solutions (UW and standard HTK) in a porcine
model of KTx. Due to a physiological and anatomical
resemblance between pig and humans, a porcine model has
been considered suitable for experimental studies of kidney
transplantation.24e27
There is a close correlation between histological
changes and the postischemic organ situation.28,29 As the
proximal tubule considered being the most sensitive part
against ischemic injury,30,31 we have evaluated these in-
juries based on a semiquantitative scoring system of acute
tubular injury and compared the histopathological
changes of the transplanted organs in each group during 7
days follow-up. The results showed deterioration of the
scores in each group after reperfusion parallel with a riseFigure 7 Mean values and standard error of mean of urine
osmolarity (mosm/L) in three groups of UW, standard HTK, and
HTK-N during the experimental study (pre-, postreperfusion,
3rd day and 7th day after transplantation).
rsity from ClinicalKey.com by Elsevier on June 05, 2018.
. Copyright ©2018. Elsevier Inc. All rights reserved.
Figure 8 Samples of the microscopic view from the histo-
pathological results of the transplanted kidneys at 7th post-
operative day. All biopsies were stained with Gimsa stain. The
nucleoli in regenerating epithelial cells are seen in all pictures
(arrows). HTK-N Z new histidine-tryptophan ketoglutarate
solution; standard HTK Z standard histidine-tryptophan keto-
glutarate solution; UWZ University of Wisconsin solution.
112 M. Golriz et al.in BUN and creatinine values without any significant dif-
ference. Furthermore, the regeneration of the proximal
tubule after kidney transplantation can be considered as
the crucial step towards the restoration of renal func-
tion.22 The more complete the regeneration is, the better
prognosis for the kidney function is expected.32,33 In our
study also, on the 7th postoperative day, compared with
the 3rd day, we could achieve better scores. Simultaneous
comparison of the results of BUN and creatinine also showsDownloaded for Anonymous User (n/a) at Nazarbayev Universi
For personal use only. No other uses without permission. Ca milder rise of the values between 3rd day and 7th day in
comparison to the first 3 posttransplant days. Based on the
histopathological results, HTK-N solution depicted com-
parable results with UW and standard HTK without any
significant difference.
In our study, in the pig kidneys transplanted after 30
hours of cold ischemia, according to clinical standards the
new HTK-N solution seems to be as protective as the stan-
dard HTK and UW used in many transplantation centers
world-wide.34e39 This result, however, is not consistent
with recent findings in the literature for HTK-N. There are
several reports on a significant gain in protective efficacy in
rat liver cell and liver ischemia-reperfusion models.15,40,41
Moreover, positive results are published in rat liver endo-
thelial cells and isolated hepatocytes.17,18,42,43 Even in rat
heart ischemia-reperfusion studies, HTK-N is evaluated
with positive results.14,44e47 Recently positive preservation
results were also described in rat and human ar-
teries.13,18,48 Although the experimental models used in
these papers are not completely comparable with patients,
there are a number of reports in favor of HTK-N as
compared with standard HTK or UW.
The HTK-N solution differs from standard HTK in some
points, which are actually discussed to be decisive for the
limit of ischemia tolerance in solid organs and the degree of
ischemia-reperfusion injury.2,16,49 The main points are: (1)
its higher antioxidative capacity; (2) its reduced histidine
content; (3) its higher magnesium and calcium content; and
(4) its lower chloride and the replacement of mannitol by
raffinose as osmolyte (Table 1). The most important inno-
vative difference is that HTK-N is supplemented by the
synthetic iron-catalase-mimic LK614 and the iron com-
plexing deferoxamine.50 LK614 is classified as a cell-
permeable scavenger of free reactive oxygen species, so-
called free radicals. Free radicals in aerobiosis have sig-
nificant functions in cell signaling.51,52 In the reperfusion
phase after a prolonged ischemic period, they are one of
the main causes of the so-called ischemia-reperfusion
injury. They are able to oxidize and impair nearly every cell
component by their high oxidation potential.2,16,49e54
Deferoxamine, a membrane permeable iron complex, is
working in the same direction. Under physiologic condi-
tions, the fraction of free iron in cells is kept extremely
low.51,55 It increases, however, e.g., late in ischemia-
caused acidosis and/or in destruction of mitochondrial
membranes. In these conditions, it reacts with H2O2, a side-
product and regulator of cell metabolism, forming the
especially aggressive hydroxyl radicals. This happens via a
Fenton reaction, which can work like a vicious cycle and
thereby potentiates the problem of free radical injury.
Additional free iron in the HTK-N solution should work as a
further antioxidant besides LK614.43,50
A further central modification in HTK-N may be the
reduction of the histidine buffer by about one-third in favor
of the addition of acetyl-histidine. The hypothesis behind
this is a possible toxic effect of products of histidine
oxidation.42 This modification, however, also reduces the
buffer capacity of HTK-N compared with Custodiol in the
range of pH 7.0 to 6.0, which typically is found in long-
lasting ischemic periods.56,57 This results from the pKs
value of acetyl-histidine which at 20C is 7.25 and 0.3e0.4
units higher at 5C. But the relevancy of this effect remainsty from ClinicalKey.com by Elsevier on June 05, 2018.
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Figure 9 Comparison of the histopathological results based
on the semi quantitative scores through KuruskaleWallis test.
The vertical line is the calculated score regarding the semi-
quantitative scoring system. The rectangles depict the range
between the lower (25%) and upper (75%) quarter of the
evaluation. The median is represented by the horizontal line in
the middle of the rectangles. CIT Z cold ischemia time; HTK-
NZ new histidine-tryptophan ketoglutarate solution; standard
HTK Z standard histidine-tryptophan ketoglutarate solution;
UWZ University of Wisconsin solution.
Preservation solution in kidney transplantation 113
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HTK-N has been increased from 4 mmol/L to 8 mmol/L. This
approach is known to be very protective especially during
ischemia, as shown in the early version of the standard HTK
solution.58 Magnesium in several respects works like a
calcium-antagonistic drug. High magnesium in dog hearts
after warm ischemia and reperfusion was shown to result in
reperfusion arrhythmias, which became severe when HTK
was reapplied during an ischemic period.58,59 These ar-
rhythmias were a form of calcium paradox caused by cal-
cium depletion of the cellular glycocalyx and could be
relieved by the reduction of magnesium or calcium sup-
plementation.23,57e59 From this point of view it is conse-
quent, which besides 8mM magnesium in HTK-N contains
more calcium than Custodiol or UW. Finally, in HTK-N,
chloride concentration is reduced from 50 mmol/L to
30 mmol/L and mannitol is substituted by raffinose, an
effective way to reduce the risk of cell swelling by the
solution. This may be a main issue in liver preservation,
because hepatocytes are permeable for manitol but
impermeable for raffinose.
In summary, HTK-N should improve the preservation ef-
ficiency by reducing the risk of uncontrolled free radicals,
possible toxicity of degradation products of histidine, fast
energy deficit, and cell edema. Therefore, we had ex-
pected to find real functional or pathological advantages in
pig kidney preservation and transplantation. Certainly, re-
sults in cell culture or in isolated rat organs are far from big
animal or patient conditions.53,60e62 Nevertheless, an
advantage of HTK-N compared with the standard solutions
such as Custodiol and UW may become measurable in
clinical setting, where additional factors such as old-for-old
organ, extremely long ischemia time, or marginal organs
require specific qualities of a preservation solution. Hence,
it should be justifiable to start such studies in the view of
the experimental results obtained in the pig model of kid-
ney transplantation shown here.References
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